IN2012DN00423A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00423A IN2012DN00423A IN423DEN2012A IN2012DN00423A IN 2012DN00423 A IN2012DN00423 A IN 2012DN00423A IN 423DEN2012 A IN423DEN2012 A IN 423DEN2012A IN 2012DN00423 A IN2012DN00423 A IN 2012DN00423A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0900904 | 2009-07-02 | ||
| PCT/EP2010/003946 WO2011000551A1 (en) | 2009-07-02 | 2010-07-02 | Exosome based treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00423A true IN2012DN00423A (en) | 2015-05-15 |
Family
ID=42989304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN423DEN2012 IN2012DN00423A (en) | 2009-07-02 | 2012-01-16 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8932855B2 (en) |
| EP (1) | EP2448595B1 (en) |
| JP (1) | JP2012531391A (en) |
| KR (1) | KR20120081972A (en) |
| CN (2) | CN107412755A (en) |
| AU (1) | AU2010268367B2 (en) |
| BR (1) | BRPI1013957A2 (en) |
| CA (1) | CA2766833A1 (en) |
| IL (1) | IL217291A0 (en) |
| IN (1) | IN2012DN00423A (en) |
| MX (1) | MX2011013452A (en) |
| RU (1) | RU2012103482A (en) |
| WO (1) | WO2011000551A1 (en) |
| ZA (1) | ZA201109226B (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2749393T3 (en) | 2009-04-17 | 2020-03-20 | Univ Oxford Innovation Ltd | Composition for delivery of genetic material |
| US9266957B2 (en) | 2009-11-10 | 2016-02-23 | Mayo Foundation For Medical Education And Research | Methods and materials for treating renal cell carcinoma and glioblastoma multiforme |
| WO2011097480A1 (en) | 2010-02-05 | 2011-08-11 | University Of Louisville Research Foundation, Inc. | Exosomal compositions and methods for the treatment of disease |
| SG183579A1 (en) * | 2011-02-11 | 2012-09-27 | Agency Science Tech & Res | Methods of detecting therapeutic exosomes |
| US20140308212A1 (en) | 2011-11-07 | 2014-10-16 | University Of Louisville Research Foundation, Inc. | Edible plant-derived microvesicle compositions for diagnosis and treatment of disease |
| GB201121070D0 (en) * | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
| CN104321062B (en) * | 2012-04-03 | 2018-09-25 | 兰诺龙有限公司 | Stem cell particle |
| US20150297639A1 (en) * | 2012-04-18 | 2015-10-22 | Rhode Island Hospital, A Lifespan-Partner | Treating cancer |
| EP2687219A1 (en) * | 2012-07-18 | 2014-01-22 | Universität Duisburg-Essen | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
| US9950074B2 (en) | 2012-10-12 | 2018-04-24 | Georg-August-Universität Göttingen Stiftung Öffenlichen Rechts, Universitätsmedizin | Composition and delivery vehicle for active agents and methods therefor |
| WO2014078272A1 (en) | 2012-11-13 | 2014-05-22 | Mayo Foundation For Medical Education And Research | Methods and materials for assessing immune system profiles |
| CN112795533A (en) | 2013-03-13 | 2021-05-14 | 迈阿密大学 | Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids |
| KR102156290B1 (en) | 2013-03-13 | 2020-09-15 | 쫑 리 | Microvesicle and method for producing the same |
| EP2981284A1 (en) * | 2013-04-05 | 2016-02-10 | Kyushu University National University Corporation | Anti-tumor dna vaccine |
| WO2014182761A1 (en) * | 2013-05-09 | 2014-11-13 | Mayo Foundation For Medical Education And Research | Treating patients based on immune subtypes |
| GB201317887D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product |
| CN103468642A (en) * | 2013-09-23 | 2013-12-25 | 山西大学 | Method for separating exosome from cell culture medium |
| CN104726410B (en) * | 2013-12-23 | 2019-09-17 | 浙江大学 | A kind of efflux body and its application with immune suppression function |
| CN103816535B (en) * | 2014-03-04 | 2015-02-18 | 中国人民解放军总医院第一附属医院 | Tumour vaccine and preparation method thereof |
| US20170035700A1 (en) * | 2014-04-11 | 2017-02-09 | University Of Louisville Research Foundation, Inc. | Coated edible plant-derived microvesicle compositions and methods for using the same |
| CN104341530B (en) * | 2014-10-28 | 2017-05-10 | 重庆沁涟生物医药科技股份有限公司 | Vnsak polypeptide and application thereof |
| AU2016327573B2 (en) | 2015-09-22 | 2022-07-14 | Trustees Of Boston University | Multiplexed phenotyping of nanovesicles |
| WO2017124000A1 (en) | 2016-01-14 | 2017-07-20 | The Regents Of The University Of California | 3d-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids |
| CN108885210B (en) * | 2016-02-05 | 2022-07-19 | 纳诺韦尔生物科学有限公司 | Detection of exosomes with surface markers |
| WO2017189281A1 (en) * | 2016-04-27 | 2017-11-02 | The Regents Of The University Of Michigan | C3d cellular and acellular vaccines for the prevention and treatment of cancer |
| CN105861430B (en) * | 2016-04-29 | 2019-07-23 | 南京大学 | A kind of excretion body, the preparation method of excretion body and its application in preparation treatment medication for treating pyemia or preparation |
| CN108473973A (en) * | 2016-09-30 | 2018-08-31 | 赛尔莱克斯生命科学公司 | Including the composition of the excretion body of load albumen and preparation and the method for delivering the composition |
| CN108324735B (en) * | 2017-01-20 | 2024-02-09 | 李莉 | Exosome preparation for treating diseases and application thereof |
| US11760975B2 (en) * | 2017-03-31 | 2023-09-19 | Wisconsin Alumi Research Foundation | Generation of therapeutic cells using extracellular components of target organs |
| US10815520B2 (en) | 2017-04-07 | 2020-10-27 | University Of Louisville Research Foundation, Inc. | Nanovesicles, methods, and systems for diagnosis and prognosis of cancer |
| WO2018208681A1 (en) * | 2017-05-08 | 2018-11-15 | Beckman Coulter, Inc. | Compositions and methods for lysis of red blood cells |
| EP3438250B1 (en) * | 2017-07-31 | 2022-12-07 | Rheinische Friedrich-Wilhelms-Universität Bonn | Cell derived extracellular vesicles for the treatment of diseases |
| CN111527199A (en) | 2017-11-16 | 2020-08-11 | 得克萨斯大学体系董事会 | Method for preparing exosomes derived from MSCs |
| CN107988153B (en) * | 2017-12-15 | 2021-05-18 | 英科博雅生命科技有限公司 | Method for separating exosome from human umbilical cord blood mesenchymal stem cell source and used reagent |
| CN108587998B (en) * | 2018-05-17 | 2021-05-18 | 浙江大学 | Exosome, preparation method of exosome and application of exosome in preparation of medicine for treating skin superficial tumors |
| CN108635372A (en) * | 2018-05-17 | 2018-10-12 | 广东芙金干细胞再生医学有限公司 | A kind of preparation method of the biological agent of human mesenchymal stem cell source excretion body |
| CN108795852A (en) * | 2018-06-27 | 2018-11-13 | 华中科技大学 | A kind of preparation method, product and its application of people's myoblast excretion body |
| US11162143B2 (en) | 2018-10-21 | 2021-11-02 | The University Of Kansas | Methods for generating therapeutic delivery platforms |
| EP3866981A4 (en) * | 2018-10-21 | 2022-09-07 | The University of Kansas | Methods for generating therapeutic delivery platforms |
| CN111840528A (en) * | 2020-06-17 | 2020-10-30 | 河北大学 | Tumor vaccine of exosome combined immune checkpoint blocking agent and preparation method thereof |
| KR102559516B1 (en) * | 2020-08-31 | 2023-07-26 | 경희대학교 산학협력단 | Composition comprising milk exosomes for inducing browning of white adipose tissue |
| CN113960313B (en) * | 2021-12-22 | 2022-04-12 | 上海思路迪医学检验所有限公司 | Exosome ALK fusion protein magnetic immunochemiluminescence detection kit |
| GB202212626D0 (en) * | 2022-08-31 | 2022-10-12 | Terasom S R O | Cancer vaccine |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0756604A1 (en) | 1994-04-22 | 1997-02-05 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Melanoma antigens |
| US7084239B1 (en) | 1997-10-08 | 2006-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Cancer peptides of NY-ESO-1/CAG-3 |
| US6432679B1 (en) * | 1998-06-12 | 2002-08-13 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220 |
| FR2785543B1 (en) * | 1998-11-05 | 2003-02-28 | Inst Nat Sante Rech Med | MODIFIED EXOSOMES AND USES |
| US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US20040241176A1 (en) | 2000-04-27 | 2004-12-02 | Ap Cells. Inc. | Method of producing membrane vesicles |
| CZ299669B6 (en) | 2000-07-28 | 2008-10-08 | Liponova Ag | Medicament for immunotherapy of malign tumors |
| JP4900884B2 (en) | 2000-07-31 | 2012-03-21 | 株式会社グリーンペプタイド | Tumor antigen |
| DE10360456A1 (en) | 2003-12-22 | 2005-07-28 | Vaecgene Biotech Gmbh | Tumor antigens and their use |
| CA2504279A1 (en) | 2005-04-15 | 2006-10-15 | University Of Saskatchewan | Materials and method of modulating the immune response using t helper-antigen presenting cells |
| CN1322115C (en) * | 2005-07-06 | 2007-06-20 | 清华大学 | Ectobody loaded with exogenous ligand molecule and its preparation method and application |
-
2010
- 2010-07-02 CN CN201710145377.XA patent/CN107412755A/en active Pending
- 2010-07-02 WO PCT/EP2010/003946 patent/WO2011000551A1/en active Application Filing
- 2010-07-02 JP JP2012516589A patent/JP2012531391A/en active Pending
- 2010-07-02 US US13/381,429 patent/US8932855B2/en active Active
- 2010-07-02 BR BRPI1013957A patent/BRPI1013957A2/en not_active Application Discontinuation
- 2010-07-02 CA CA2766833A patent/CA2766833A1/en not_active Abandoned
- 2010-07-02 MX MX2011013452A patent/MX2011013452A/en not_active Application Discontinuation
- 2010-07-02 CN CN2010800300523A patent/CN102470167A/en active Pending
- 2010-07-02 AU AU2010268367A patent/AU2010268367B2/en active Active
- 2010-07-02 EP EP10732289.3A patent/EP2448595B1/en active Active
- 2010-07-02 KR KR1020127002892A patent/KR20120081972A/en not_active Application Discontinuation
- 2010-07-02 RU RU2012103482/15A patent/RU2012103482A/en not_active Application Discontinuation
-
2011
- 2011-12-14 ZA ZA2011/09226A patent/ZA201109226B/en unknown
- 2011-12-29 IL IL217291A patent/IL217291A0/en unknown
-
2012
- 2012-01-16 IN IN423DEN2012 patent/IN2012DN00423A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120081972A (en) | 2012-07-20 |
| EP2448595B1 (en) | 2017-06-14 |
| US20120183575A1 (en) | 2012-07-19 |
| ZA201109226B (en) | 2014-05-28 |
| BRPI1013957A2 (en) | 2016-04-05 |
| WO2011000551A1 (en) | 2011-01-06 |
| US8932855B2 (en) | 2015-01-13 |
| MX2011013452A (en) | 2012-04-30 |
| EP2448595A1 (en) | 2012-05-09 |
| CN107412755A (en) | 2017-12-01 |
| CA2766833A1 (en) | 2011-01-06 |
| RU2012103482A (en) | 2013-08-10 |
| CN102470167A (en) | 2012-05-23 |
| AU2010268367B2 (en) | 2016-10-20 |
| AU2010268367A1 (en) | 2012-01-19 |
| IL217291A0 (en) | 2012-02-29 |
| JP2012531391A (en) | 2012-12-10 |